Short-term intraocular pressure changes after intravitreal bevacizumab injection

Intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) have become more popular quickly in recent years. Bevacizumab is an anti- vascular endothelial growth factor agent (anti-VEGF) used to treat choroidal neovascularization and retinal vascular disorders. Rare long lasting...

Full description

Bibliographic Details
Main Authors: Ali Dehghani, Habib Jafari, Naser Shoeibi
Format: Article
Published: Mashhad University of Medical Sciences 2014-06-01
Series:Reviews in Clinical Medicine
Online Access: